Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

: Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; for the TECOS Study Group

: 2015

: New England Journal of Medicine

: 373

: 3

: 232

: 242

: 11

: 0028-4793

DOI: https://doi.org/10.1056/NEJMoa1501352